Capricor Therapeutics, Inc. (CAPR) Downgraded to Hold by Jones Trading

Market Context

Capricor Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $3.96 with a market capitalization of $1.2B. The stock has declined 38.3% over the past 52 weeks.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Jones Trading's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Capricor Therapeutics, Inc.

Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 31, 2026	Jones Trading	Hold	N/A
Jul 30, 2026	Piper Sandler	Neutral	N/A
Jul 30, 2026	Cantor Fitzgerald	Neutral	N/A
Jul 30, 2026	HC Wainwright & Co.	Neutral	N/A
May 13, 2026	HC Wainwright & Co.	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View CAPR Stock Page